Javascript must be enabled to continue!
EP2.21 Periacetabular Osteotomies Lead to Improved Long-Term Patient-Reported Outcomes: A Systematic Review
View through CrossRef
Abstract
Introduction: Periacetabular osteotomy (PAO) has demonstrated favorable outcomes for the treatment of hip dysplasia at short and midterm follow-up. The durability of these outcomes at long term follow-up is still being established. The primary purpose of this study was to conduct a comprehensive systematic review to assess the reoperation rates and long-term patient-reported outcomes (PROs) of PAO.
Method: A systematic review of the literature was conducted in August 2023, with the following keywords: (periacetabular osteotomy) AND (patient-reported) AND (outcomes) in PubMed, Cochrane, and Scopus. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria was used. Only studies that reported on patient-reported outcomes with a mean of 10-year follow-up were included. Background article information was recorded, including article title, author, study design, level of evidence, patient demographics, radiographic information, intraoperative data, patient-reported outcomes, psychometric thresholds, and secondary surgeries.
Results: A total of 8 studies covering 984 patients who underwent periacetabular osteotomies were included in this systematic review. Five studies were level III evidence and 3 were level IV. The mean study follow-up periods ranged between 120.0-348.2 months. The mean ages within studies ranged between 23.0 to 39.9 years at the time of surgery. Seven out of 8 studies reported a significant improvement between preoperative and postoperative PROs with the remaining study not including preoperative PROs. Mean modified Harris Hip Scores (mHHS) ranged from 61.9-83.0 preoperatively compared to 84.6-97.0 postoperatively. Mean Merle d’Aubigne-Postel scores ranged from 14.0-15.0 preoperatively and 16.0-17.0 postoperatively. Overall, secondary surgery rates ranged from 1.9-57.3% with conversion to THA rates of 0-56%. Significant risk factors for failure of PAO, defined as conversion to THA, and/or poor outcomes scores, included increasing age at the time of surgery (four studies), preoperative arthritis (Tönnis Grade >1, four studies), postoperative anterior femoral coverage >27 degrees (2 studies), and preoperative patient-reported scores (Postel score <15, 2 studies).
Conclusion: Patients undergoing PAO surgery for the treatment of hip dysplasia demonstrated significant improvement in PROs, but studies demonstrated variable rates of secondary surgeries at mean 10-year follow-up. Risk factors for failure included advanced age, Tönnis Grade >1, and preoperative patient-reported outcome scores. These findings provide important information on the long-term durability of PAO outcomes.
Significance/Clinical Relevance: This study is one of the first systematic reviews to examine long-term patient-reported outcomes after periacetabular osteotomy, allowing for a longitudinal scope of how patients are faring after PAO.
Oxford University Press (OUP)
Title: EP2.21 Periacetabular Osteotomies Lead to Improved Long-Term Patient-Reported Outcomes: A Systematic Review
Description:
Abstract
Introduction: Periacetabular osteotomy (PAO) has demonstrated favorable outcomes for the treatment of hip dysplasia at short and midterm follow-up.
The durability of these outcomes at long term follow-up is still being established.
The primary purpose of this study was to conduct a comprehensive systematic review to assess the reoperation rates and long-term patient-reported outcomes (PROs) of PAO.
Method: A systematic review of the literature was conducted in August 2023, with the following keywords: (periacetabular osteotomy) AND (patient-reported) AND (outcomes) in PubMed, Cochrane, and Scopus.
The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) criteria was used.
Only studies that reported on patient-reported outcomes with a mean of 10-year follow-up were included.
Background article information was recorded, including article title, author, study design, level of evidence, patient demographics, radiographic information, intraoperative data, patient-reported outcomes, psychometric thresholds, and secondary surgeries.
Results: A total of 8 studies covering 984 patients who underwent periacetabular osteotomies were included in this systematic review.
Five studies were level III evidence and 3 were level IV.
The mean study follow-up periods ranged between 120.
0-348.
2 months.
The mean ages within studies ranged between 23.
0 to 39.
9 years at the time of surgery.
Seven out of 8 studies reported a significant improvement between preoperative and postoperative PROs with the remaining study not including preoperative PROs.
Mean modified Harris Hip Scores (mHHS) ranged from 61.
9-83.
0 preoperatively compared to 84.
6-97.
0 postoperatively.
Mean Merle d’Aubigne-Postel scores ranged from 14.
0-15.
0 preoperatively and 16.
0-17.
0 postoperatively.
Overall, secondary surgery rates ranged from 1.
9-57.
3% with conversion to THA rates of 0-56%.
Significant risk factors for failure of PAO, defined as conversion to THA, and/or poor outcomes scores, included increasing age at the time of surgery (four studies), preoperative arthritis (Tönnis Grade >1, four studies), postoperative anterior femoral coverage >27 degrees (2 studies), and preoperative patient-reported scores (Postel score <15, 2 studies).
Conclusion: Patients undergoing PAO surgery for the treatment of hip dysplasia demonstrated significant improvement in PROs, but studies demonstrated variable rates of secondary surgeries at mean 10-year follow-up.
Risk factors for failure included advanced age, Tönnis Grade >1, and preoperative patient-reported outcome scores.
These findings provide important information on the long-term durability of PAO outcomes.
Significance/Clinical Relevance: This study is one of the first systematic reviews to examine long-term patient-reported outcomes after periacetabular osteotomy, allowing for a longitudinal scope of how patients are faring after PAO.
Related Results
Opposing effects of prostaglandin receptor EP2 signaling in mouse immune cells and neurons after status epilepticus
Opposing effects of prostaglandin receptor EP2 signaling in mouse immune cells and neurons after status epilepticus
AbstractA multidimensional inflammatory response ensues after status epilepticus (SE), driven partly by cyclooxygenase-2 mediated activation of prostaglandin EP2 receptors. Here we...
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Characterisation of Oxylipin Receptors in the Cnidarian-Dinoflagellate Symbiosis
Characterisation of Oxylipin Receptors in the Cnidarian-Dinoflagellate Symbiosis
<p dir="ltr"><b>The success of scleractinian corals relies on their ability to establish a symbiotic relationship with dinoflagellate algae from the family Symbiodiniac...
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Structural Insights into Selective and Dual Antagonism of EP2 and EP4 Prostaglandin Receptors
Structural Insights into Selective and Dual Antagonism of EP2 and EP4 Prostaglandin Receptors
AbstractProstaglandin E2 (PGE2) signaling through EP2 and EP4 receptors plays a crucial role in inflammation, pain, and cancer progression. Selective and dual antagonists of these ...

